AAAAAA

   
Results: 1-8 |
Results: 8
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOLLOWED BY POSTTRANSPLANT DOXORUBICIN AND TAXOL AS INITIAL THERAPY FOR METASTATIC BREAST-CANCER - HEMATOPOIETIC TOLERANCE AND EFFICACY
Authors: DEMAGALHAESSILVERMAN M HAMMERT L LEMBERSKY B LISTER J RYBKA W BALL E
Citation: M. Demagalhaessilverman et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOLLOWED BY POSTTRANSPLANT DOXORUBICIN AND TAXOL AS INITIAL THERAPY FOR METASTATIC BREAST-CANCER - HEMATOPOIETIC TOLERANCE AND EFFICACY, Bone marrow transplantation, 21(12), 1998, pp. 1207-1211
INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECT IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: DEMAGALHAESSILVERMAN M DONNENBERG A HAMMERT L LISTER J MYERS D SIMPSON J BALL E
Citation: M. Demagalhaessilverman et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECT IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 20(2), 1997, pp. 175-177
DELAYED HEMOLYSIS AFTER MINOR ABO MISMATCHED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: BROKETA G SIMPSON JK HAMMERT L BALL E KISS JE TRIULZI DJ
Citation: G. Broketa et al., DELAYED HEMOLYSIS AFTER MINOR ABO MISMATCHED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Transfusion, 37(9), 1997, pp. 147-147
MOBILIZATION OF BLOOD STEM-CELLS FOR ALLOGENEIC TRANSPLANTATION USINGMODERATELY HIGH-DOSE OF RH-GCSF
Authors: DEMAGALHAESSILVERMAN M BARILLA D DONNENBERG A HAMMERT L RYBKA WR SIMPSON J BALL ED
Citation: M. Demagalhaessilverman et al., MOBILIZATION OF BLOOD STEM-CELLS FOR ALLOGENEIC TRANSPLANTATION USINGMODERATELY HIGH-DOSE OF RH-GCSF, Blood, 90(10), 1997, pp. 4207-4207
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) FOR HEMATOLOGICAL MALIGNANCY WITH TACROLIMUS MONOTHERAPY AS PROPHYLAXIS FOR GRAFT-VS-HOST DISEASE (GVRD)
Authors: BALL ED DEMAGALHAESSILVERMAN M RYBKA WR KISS JC HAMMERT L SIMPSON J WILSON J
Citation: Ed. Ball et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) FOR HEMATOLOGICAL MALIGNANCY WITH TACROLIMUS MONOTHERAPY AS PROPHYLAXIS FOR GRAFT-VS-HOST DISEASE (GVRD), Blood, 90(10), 1997, pp. 4395-4395
HEMATOLOGIC COMPLICATIONS OF PASSENGER LYMPHOCYTES IN ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: SIMPSON JK BROKETA G DEMAGALHAESSILVERMAN M HAMMERT L BALL E KISS JE LOPEZPLAZA I TRIULZI DJ
Citation: Jk. Simpson et al., HEMATOLOGIC COMPLICATIONS OF PASSENGER LYMPHOCYTES IN ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4511-4511
FACTORS INFLUENCING MOBILIZATION AND ENGRAFTMENT IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) UNDERGOING PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION
Authors: DEMAGALHAESSILVERMAN M DONNENBERG A HAMMERT L LISTER J RYBKA WR SIMPSON J BALL ED
Citation: M. Demagalhaessilverman et al., FACTORS INFLUENCING MOBILIZATION AND ENGRAFTMENT IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) UNDERGOING PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION, Blood, 90(10), 1997, pp. 941-941
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOLLOWED BY POSTTRANSPLANT DOXORUBICIN AND TAXOL AS INITIAL THERAPY FOR METASTATIC BREAST-CANCER - HEMATOPOIETIC TOLERANCE AND EFFICACY
Authors: DEMAGALHAESSILVERMAN M HAMMERT L LEMBERSKY B LISTER J RYBKA W BALL E
Citation: M. Demagalhaessilverman et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOLLOWED BY POSTTRANSPLANT DOXORUBICIN AND TAXOL AS INITIAL THERAPY FOR METASTATIC BREAST-CANCER - HEMATOPOIETIC TOLERANCE AND EFFICACY, Blood, 90(10), 1997, pp. 1704-1704
Risultati: 1-8 |